Profil
Dr. Rebecca Pruss is Chief Scientific Officer at Trophos SA. Dr. Pruss was previously employed as Head-Exploratory Research by Sanofi-Synthelabo Canada, Inc.
Anciens postes connus de Rebecca Pruss
| Sociétés | Poste | Fin |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Directeur Technique/Scientifique/R&D | 01/10/2015 |
| Sanofi-Synthelabo Canada, Inc. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
| Sanofi-Synthelabo Canada, Inc. |
